CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas (vol 13, 3739, 2022)

被引：0
|
作者：
Niborski, Leticia Laura [1 ,2 ,3 ]
Gueguen, Paul [1 ,2 ]
Ye, Mengliang [1 ,2 ]
Thiolat, Allan [4 ,5 ]
Ramos, Rodrigo Nalio [1 ,2 ,3 ]
Caudana, Pamela [1 ,2 ,3 ]
Denizeau, Jordan [1 ,2 ,3 ]
Colombeau, Ludovic [6 ]
Rodriguez, Raphael [6 ]
Goudot, Christel [1 ,2 ]
Luccarini, Jean-Michel [7 ]
Soude, Anne [7 ]
Bournique, Bruno [7 ]
Broqua, Pierre [7 ]
Pace, Luigia [1 ,2 ]
Baulande, Sylvain [8 ]
Sedlik, Christine [1 ,2 ,3 ]
Quivy, Jean-Pierre [1 ,9 ,10 ]
Almouzni, Genevieve [1 ,9 ,10 ]
Cohen, Jose L. [4 ,5 ]
Zueva, Elina [1 ,2 ]
Waterfall, Joshua J. [1 ,3 ,11 ]
Amigorena, Sebastian [1 ,2 ]
Piaggio, Eliane [1 ,2 ,3 ]
机构：
[1] PSL Res Univ, Inst Curie, F-75005 Paris, France
[2] INSERM U932, F-75005 Paris, France
[3] Inst Curie, Translat Res Dept, F-75005 Paris, France
[4] Univ Paris Est Creteil Val Marne, Univ Paris Est, UMR S955, Creteil, France
[5] INSERM, Equipe 21, U955, Creteil, France
[6] PSL Res Univ, CNRS UMR3666, Inst Curie, INSERM UMR3666,Chem Biol Canc,Equipe Labellisee L, Paris, France
[7] Inventiva, 50 Rue Dijon, F-21121 Daix, France
[8] Inst Curie Res Ctr, Inst Curie Genom Excellence ICGex Platform, Paris, France
[9] PSL Res Univ, CNRS, Inst Curie, Equipe Labellisee Ligue Canc,UMR3664, Paris, France
[10] Sorbonne Univ, UPMC Univ Paris 06, CNRS, UMR3664, F-7005 Paris, France
[11] INSERM U830, F-75005 Paris, France
来源：
NATURE COMMUNICATIONS | 2023年 / 14卷 / 01期
关键词：
D O I：
10.1038/s41467-023-38931-6
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
    Leticia Laura Niborski
    Paul Gueguen
    Mengliang Ye
    Allan Thiolat
    Rodrigo Nalio Ramos
    Pamela Caudana
    Jordan Denizeau
    Ludovic Colombeau
    Raphaël Rodriguez
    Christel Goudot
    Jean-Michel Luccarini
    Anne Soudé
    Bruno Bournique
    Pierre Broqua
    Luigia Pace
    Sylvain Baulande
    Christine Sedlik
    Jean-Pierre Quivy
    Geneviève Almouzni
    José L. Cohen
    Elina Zueva
    Joshua J. Waterfall
    Sebastian Amigorena
    Eliane Piaggio
    Nature Communications, 13
  • [2] CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
    Niborski, Leticia Laura
    Gueguen, Paul
    Ye, Mengliang
    Thiolat, Allan
    Ramos, Rodrigo Nalio
    Caudana, Pamela
    Denizeau, Jordan
    Colombeau, Ludovic
    Rodriguez, Raphael
    Goudot, Christel
    Luccarini, Jean-Michel
    Soude, Anne
    Bournique, Bruno
    Broqua, Pierre
    Pace, Luigia
    Baulande, Sylvain
    Sedlik, Christine
    Quivy, Jean-Pierre
    Almouzni, Genevieve
    Cohen, Jose L.
    Zueva, Elina
    Waterfall, Joshua J.
    Amigorena, Sebastian
    Piaggio, Eliane
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
    Leticia Laura Niborski
    Paul Gueguen
    Mengliang Ye
    Allan Thiolat
    Rodrigo Nalio Ramos
    Pamela Caudana
    Jordan Denizeau
    Ludovic Colombeau
    Raphaël Rodriguez
    Christel Goudot
    Jean-Michel Luccarini
    Anne Soudé
    Bruno Bournique
    Pierre Broqua
    Luigia Pace
    Sylvain Baulande
    Christine Sedlik
    Jean-Pierre Quivy
    Geneviève Almouzni
    José L. Cohen
    Elina Zueva
    Joshua J. Waterfall
    Sebastian Amigorena
    Eliane Piaggio
    Nature Communications, 14
  • [4] SUV39H1 controls the differentiation of CD8+tissue resident memory T cell precursors
    Suarez, Guadalupe
    Heurtebise-Chretien, Sandrine
    Bonte, Pierre-Emmanuele
    Sebastian Amigorena, Diego
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 79 - 79
  • [5] Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function
    Wang, Yuning
    Zhao, Guo
    Wang, Shuhang
    Li, Ning
    MEDCOMM, 2024, 5 (05):
  • [6] Dynamics of CD8+T cell subsets correlated with clinical response to anti-PD-1 antibody
    Kawakami, Yutaka
    Ohta, Shigeki
    CANCER SCIENCE, 2021, 112 : 964 - 964
  • [7] Redistribution of CD8+T cell subsets in metastatic renal cell carcinoma patients treated with anti-PD-1 therapy
    De Biasi, Sara
    Guida, Annalisa
    Lo Tartaro, Domenico
    Fanelli, Martina
    Depenni, Roberta
    Dominici, Massimo
    Finak, Greg
    Porta, Camillo
    Paolini, Annamaria
    Borella, Rebecca
    Bertoldi, Carlo
    Cossarizza, Andrea
    Sabbatini, Roberto
    Gibellini, Lara
    CYTOMETRY PART A, 2022, 101 (07) : 597 - 605
  • [8] MDSC subtypes and CD39 expression on CD8+T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC
    Koh, Jiae
    Kim, Youjin
    Lee, Kyoung Young
    Hur, Joon Young
    Kim, Mi Soon
    Kim, Boram
    Cho, Hee Jin
    Lee, Yeong Chan
    Bae, Yeon Hee
    Ku, Bo Mi
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (11) : 1810 - 1819
  • [9] ARID1A is a coactivator of STAT5 that contributes to CD8+T cell dysfunction and anti-PD-1 resistance in gastric cancer
    Ma, Fangqi
    Ren, Mingming
    Li, Zhongqiu
    Tang, Yujing
    Sun, Xiaoyu
    Wang, Yi
    Cao, Nida
    Zhu, Xiaohong
    Xu, Yan
    Wang, Rui
    Shen, Yumiao
    Zhao, Ruohan
    Li, Zhaoyan
    Ashrafizadeh, Milad
    Sethi, Gautam
    Wang, Furong
    Zhao, Aiguang
    PHARMACOLOGICAL RESEARCH, 2024, 210
  • [10] Serum-derived exosomal PD-L1 and tumor-infiltrating CD8+T cell expression for predicting anti-PD-1 response in NSCLC
    Shimada, Yoshihisa
    Matsubayashi, Jun
    Kudo, Yujin
    Ohira, Tatsuo
    Ikeda, Norihiko
    CANCER SCIENCE, 2021, 112 : 370 - 370
12345